All Industries

Top Therapeutics Companies

203 Therapeutics companies, sorted by total funding raised.

Surge Therapeutics

Develops an injectable intraoperative immunotherapy hydrogel to prevent post-surgical cancer recu...

Cambridge, United States1–10Biotech, Drug Discovery
Series B·$58.0M·Jul 2023
Moonwalk Biosciences

Develops precision epigenetic medicines targeting adipose biology and cardiometabolic disease usi...

South San Francisco, United States11–50Biotech, Drug Discovery
Seed·$57.0M·Jan 2024
64x Bio

High throughput design of cells for therapeutics applications.

11–50Artificial Intelligence, Healthcare
Series A·$55.0M·Jan 2022
Appia BioClosed

Develops allogeneic CAR‑iNKT cell therapies from hematopoietic stem cells to treat cancers, partn...

Los Angeles, United States11–50Biotech, Drug Discovery
Series A·$52.0M·May 2021
Somite AI

AI company building foundation models for human stem cells to accelerate cell therapy development...

Boston, United States1–10Artificial Intelligence, Biotech
Series A·$47.5M·Jun 2025
Turnstone BiologicsClosed

Clinical-stage biotech developing Selected TIL (tumor-infiltrating lymphocyte) cell therapies for...

Ottawa, Canada51–200Biotech, Therapeutics
Series C·$42.1M·Mar 2019
Hydra Biosciences, Inc.Closed

Private biopharmaceuticals company pioneering the discovery of novel drugs using its expertise in...

Cambridge, United States11–50Biotech, Drug Discovery
Series D·$40.9M·Jan 2009
Mindstate Design Labs

Next-generation psychedelic therapeutics for mental health

San Francisco, United States1–10Artificial Intelligence, Biotech
Venture Unknown·$37.2M·Nov 2024
ReceptosClosed

Biopharmaceutical company that developed immune-inflammatory therapies, notably ozanimod (RPC-106...

San Diego, United States51–200Biotech, Drug Discovery
Venture Unknown·$35.8M·Mar 2012
Permanence Bio

Developing therapeutics to stop mutations to prevent cancer

San Francisco, United States1–10Biotech, Drug Discovery
Series A·$35.0M·Jan 2026
Sorriso Pharmaceuticals

Sorriso Pharmaceuticals is a biotechnology company advancing a pipeline of disease-modifying anti...

Sandy, United States1–10biotech, pharmaceuticals
Series A·$31.0M·Dec 2021
Fate TherapeuticsIPO

Clinical-stage biopharmaceutical company developing iPSC-derived cellular immunotherapies for aut...

La Jolla, United States51–200Biotech, Life Sciences
Series B·$30.0M·Nov 2009
RZ Nomics

Rznomics is a South Korean RNA therapeutics biotech developing gene therapies for cancer, degener...

Yongin, South Korea11–50Biotech, Therapeutics
Series C·$30.0M·Jan 2023
Scioto BiosciencesAcquired

Scioto is a preclinical stage company developing innovative therapies devoted to having a transfo...

Indianapolis, United States1–10Food & Beverage, Biotech
Series B·$28.3M·Aug 2020
Function Oncology

Develops a CRISPR-powered personalized functional genomics platform to profile patient tumors and...

San Diego, United States1–10Biotech, Diagnostics
Series A·$28.0M·Apr 2023
TwoStep Therapeutics

A versatile integrin-binding peptide, PIP

San Carlos, United States1–10Biotech, Drug Discovery
Series A·$27.6M·Jan 2026
Westlake Therapeutics

Biotech developing engineered red blood cell therapeutics for cancer, immunological, and metaboli...

Hangzhou, ChinaBiotech, Therapeutics
Series A·$27.6M·Jun 2022
S
StromedixAcquired

Biotechnology company developing innovative therapies for fibrosis and organ failure.

Cambridge, United States1–10Biotech, Therapeutics
Series C·$25.0M·Jan 2011
AmgenIPO

Develops and manufactures biologic medicines treating serious illnesses and improving patient out...

Thousand Oaks, United States10001+Biotech, Healthcare
Venture Unknown·$19.0M·Apr 1980
Akari TherapeuticsIPO

Biotechnology company developing advanced therapies for autoimmune and inflammatory diseases.

London, United Kingdom1–10Antibody-Drug Conjugates, Biopharmaceutical
Venture Unknown·$14.6M·Dec 2025
ModuLight

Revolutionising the treatment of severe neurological conditions

Boston, Israel11–50Biotech, Medical
Seed·$12.2M·Nov 2025
Valink Therapeutics

Discovering bispecific antibody drug-conjugates (BsADC) against cancer

Boston, United States11–50Biotech, Drug Discovery
Pre-seed·$11.8M·Oct 2025
Rejuvenation Technologies Inc.

We extend telomeres to extend the human health span

Mountain View, United States1–10Biotech, Healthcare
Seed·$10.6M·Sep 2023
Sixfold Bioscience

Delivering RNA therapies.

London, United Kingdom11–50Biotech, Drug Discovery
Seed·$10.5M·Dec 2021
SepracorAcquired

Bioactive membranes and other separation technologies for the chemical processing and pharmaceuti...

Marlborough, United States501–1000Drug Discovery, Healthcare
Venture Unknown·$10.5M·Jun 1993